SNTA Related Analyst Comments
-
Brean Maintains Buy on Synta Pharma (SNTA)
-
Synta Pharma (SNTA) Sell-Off Related to R&D Pres. Resignation, Could Be Buying Opp
-
Jefferies Sharply Raises Target on Synta Pharma (SNTA) After GALAXY Update
-
Synta Phara (SNTA) Recieves Favorable Feedback Regarding Phase 2 - Jefferies
-
Jefferies Maintains a 'Buy' on Synta Pharma. (SNTA); Still See Significant Upside
-
Jefferies Maintains Bullish View on Synta Pharma. (SNTA) on GALAXY Survival Data
-
Jefferies Maintains a 'Buy' on Synta Pharma. (SNTA); Market Reaction Excessive
-
Jefferies Sees Nearly 100% Upside in Synta Pharma. (SNTA)
-
Canaccord Genuity Reiterates a 'Buy' on Synta Pharma (SNTA); Ganetespid Update
-
Canaccord Genuity Reiterates a 'Buy' on Synta Pharma. (SNTA) Following Meeting with Management
-
Canaccord Genuity Maintains a 'Buy' on Synta Pharma. (SNTA); Q3/11 Update
-
Canaccord Genuity Maintains a 'Buy' on Synta Pharma (SNTA); Q1/11: G-pib Development in NSCLC Advances
-
Canaccord Genuity Reiterates a 'Buy' on Synta Pharmaceuticals (SYNA); Ganetespib Combo NSCLC Study to Commence
-
Barclays Maintains an 'Equalweight' on Synta Pharma. (SNTA); Early Ganetespib Activity Encouraging
Back to SNTA Stock Lookup
